344 related articles for article (PubMed ID: 34169404)
1. Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.
Jafari Khaljiri H; Jamalkhah M; Amini Harandi A; Pakdaman H; Moradi M; Mowla A
Neurotox Res; 2021 Oct; 39(5):1613-1629. PubMed ID: 34169404
[TBL] [Abstract][Full Text] [Related]
2. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
[TBL] [Abstract][Full Text] [Related]
3. Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings.
Guerrero JI; Barragán LA; Martínez JD; Montoya JP; Peña A; Sobrino FE; Tovar-Spinoza Z; Ghotme KA
BMC Infect Dis; 2021 Jun; 21(1):515. PubMed ID: 34078305
[TBL] [Abstract][Full Text] [Related]
4. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and its effects on neurological functions.
Yew MMT; Lip JQ; Ling APK
Trop Biomed; 2021 Sep; 38(3):435-445. PubMed ID: 34608117
[TBL] [Abstract][Full Text] [Related]
6. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
Zhang Y; Chen X; Jia L; Zhang Y
Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
[TBL] [Abstract][Full Text] [Related]
7. Neurological manifestations of COVID-19: A brief review.
Sachdev K; Agrawal S; Ish P; Gupta N; Raheja K
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):41-47. PubMed ID: 32859864
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.
Tsatsakis A; Calina D; Falzone L; Petrakis D; Mitrut R; Siokas V; Pennisi M; Lanza G; Libra M; Doukas SG; Doukas PG; Kavali L; Bukhari A; Gadiparthi C; Vageli DP; Kofteridis DP; Spandidos DA; Paoliello MMB; Aschner M; Docea AO
Food Chem Toxicol; 2020 Dec; 146():111769. PubMed ID: 32979398
[TBL] [Abstract][Full Text] [Related]
9. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
[TBL] [Abstract][Full Text] [Related]
10. Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection.
Jagst M; Pottkämper L; Gömer A; Pitarokoili K; Steinmann E
Curr Opin Microbiol; 2024 Jun; 79():102474. PubMed ID: 38615394
[TBL] [Abstract][Full Text] [Related]
11. Can Covid-19 attack our nervous system?
Abdel Hafez SMN
J Chem Neuroanat; 2021 Nov; 117():102006. PubMed ID: 34324964
[TBL] [Abstract][Full Text] [Related]
12. Neurological involvement of COVID-19: from neuroinvasion and neuroimmune crosstalk to long-term consequences.
Septyaningtrias DE; Susilowati R
Rev Neurosci; 2021 Jun; 32(4):427-442. PubMed ID: 33550780
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2: is there neuroinvasion?
McQuaid C; Brady M; Deane R
Fluids Barriers CNS; 2021 Jul; 18(1):32. PubMed ID: 34261487
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond.
Mussa BM; Srivastava A; Verberne AJM
Viruses; 2021 Mar; 13(3):. PubMed ID: 33802995
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review.
Azhar A; Wali MA; Rashid Q; Khan WH; Al-Hosaini K; Owais M; Kamal MA
CNS Neurol Disord Drug Targets; 2023; 22(5):643-658. PubMed ID: 35440321
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19.
Maiese A; Manetti AC; Bosetti C; Del Duca F; La Russa R; Frati P; Di Paolo M; Turillazzi E; Fineschi V
Brain Pathol; 2021 Nov; 31(6):e13013. PubMed ID: 34390282
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
Taher T; Sheikh AB; Anwar F; Khosa F
Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
[TBL] [Abstract][Full Text] [Related]
18. Nervous System Involvement in COVID-19: a Review of the Current Knowledge.
Norouzi M; Miar P; Norouzi S; Nikpour P
Mol Neurobiol; 2021 Jul; 58(7):3561-3574. PubMed ID: 33765290
[TBL] [Abstract][Full Text] [Related]
19. Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2.
Iroegbu JD; Ifenatuoha CW; Ijomone OM
Neurol Sci; 2020 Jun; 41(6):1329-1337. PubMed ID: 32424503
[TBL] [Abstract][Full Text] [Related]
20. Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets.
Kumar S; Shanker OR; Kumari N; Tripathi M; Chandra PS; Dixit AB; Banerjee J
Expert Opin Ther Targets; 2021 Jun; 25(6):509-519. PubMed ID: 34232801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
